# Clinical Trial Dataset (Auralin vs Novodra)

## ðŸ“Œ Dataset Summary
This dataset contains records of **500 patients**, out of which **350 participated in a clinical trial**.  
- None of the patients were using **Novodra** (injectable insulin) or **Auralin** (oral insulin being researched) as their primary insulin before.  
- All participants had **elevated HbA1c levels**.  
- For baseline: all 350 patients were treated with **Novodra for 4 weeks**.  
- Then, patients were split:  
  - **175 switched to Auralin** (for 24 weeks)  
  - **175 continued Novodra** (for 24 weeks)  
- Adverse reaction data was also collected.  

The trial aims to test whether **Auralin is noninferior to Novodra**, defined as the **upper bound of the 95% CI of mean HbA1c difference < 0.4%**.

---

## ðŸ“Š Table & Column Descriptions

### **patients**
- `patient_id` â†’ Unique identifier in Master Patient Index  
- `assigned_sex` â†’ Sex at birth (male/female)  
- `given_name` â†’ First name  
- `surname` â†’ Last name  
- `address` â†’ Main address  
- `city`, `state`, `zip_code`, `country` â†’ Location fields (all US)  
- `contact` â†’ Phone + Email together  
- `birthdate` â†’ Date of birth (MM/DD/YYYY); all â‰¥ 18 years  
- `weight` â†’ In pounds (lbs)  
- `height` â†’ In inches (in)  
- `bmi` â†’ Body Mass Index (kg/mÂ²); trial inclusion: **16 â‰¤ BMI â‰¤ 38**

### **treatments / treatment_cut**
- `given_name`, `surname` â†’ Patient identifiers  
- `auralin` â†’ Baselineâ€“End median daily insulin dose (units)  
- `novodra` â†’ Same for Novodra  
- `hba1c_start` â†’ HbA1c level at treatment start (%)  
- `hba1c_end` â†’ HbA1c level at treatment end (%)  
- `hba1c_change` â†’ Difference (start âˆ’ end); lower = improvement  

### **adverse_reactions**
- `given_name`, `surname` â†’ Patient identifiers  
- `adverse_reaction` â†’ Reported reaction  

---

## â„¹ï¸ Additional Information
- Insulin resistance varies per person â†’ baseline & end dose both required.  
- Trial includes diverse patients (sex, age, race, ethnicity) for better generalization.  
- **Noninferiority check**: mean HbA1c change difference (Novodra âˆ’ Auralin) CI upper bound < 0.4%.  

---

## âš ï¸ Dataset Issues

### **Dirty Data**

**patients**
- `patient_id = 9` â†’ Misspelled name *"Dsvid"* instead of *David* (**accuracy**)  
- `state` â†’ Mixed formats (full name vs abbreviation) (**consistency**)  
- `zip_code` â†’ Some 4-digit values (**validity**)  
- Missing data for 12 patients in (`address`, `city`, `state`, `zip_code`, `country`, `contact`) (**completion**)  
- Wrong datatypes in (`assigned_sex`, `zip_code`, `birthdate`) (**validity**)  
- Duplicate entries (*John Doe*) (**accuracy**)  
- One patient weight = **48 lbs** (implausible) (**accuracy**)  
- One patient height = **27 in** (implausible) (**accuracy**)  

**treatments / treatment_cut**
- `given_name`, `surname` all lowercase (**consistency**)  
- `auralin` & `novodra` contain `"u"` (**validity**)  
- `"-"` values treated as NaN (**validity**)  
- Missing values in `hba1c_change` (**completion**)  
- Duplicate entry (*Joseph Day*) (**accuracy**)  
- `hba1c_change` has **9 instead of 4** (**accuracy**)  

**adverse_reactions**
- `given_name`, `surname` all lowercase (**consistency**)  

---

### **Messy Data**

**patients**
- `contact` contains both phone + email â†’ should be split  

**treatments / treatment_cut**
- `auralin` & `novodra` should be split into **start_dose** and **end_dose**  
- `treatments` and `treatment_cut` should be merged  

**adverse_reactions**
- Should be linked to treatments, not independent  

---

## ðŸ§¹ Data Cleaning Plan (Step-by-Step)

1. **patients**
   - Fix name typos (e.g., *Dsvid â†’ David*)  
   - Standardize `state` (USPS 2-letter codes)  
   - Normalize `zip_code` to 5 digits  
   - Handle missing values (imputation / leave blank with flag)  
   - Convert datatypes (sex â†’ category, birthdate â†’ datetime, zip â†’ string)  
   - Remove duplicates (John Doe, etc.)  
   - Flag outliers (weight 48 lbs, height 27 in)  
   - Recompute `bmi` and check inclusion criteria (16 â‰¤ BMI â‰¤ 38)  
   - Split `contact` into `phone`, `email`  

2. **treatments / treatment_cut**
   - Title-case names  
   - Remove `"u"` from doses  
   - Split into `start_dose`, `end_dose`  
   - Replace `"-"` with NaN  
   - Merge `treatments` + `treatment_cut`  
   - Recompute `hba1c_change = hba1c_start âˆ’ hba1c_end`  
   - Fix incorrect values (e.g., 9 â†’ 4)  
   - Drop duplicate (Joseph Day)  

3. **adverse_reactions**
   - Title-case names  
   - Merge with patients & treatments for complete clinical dataset  

---

## âœ… Final Outputs
- Clean tables: `patients_clean.csv`, `treatments_clean.csv`, `adverse_reactions_clean.csv`  
- Merged master file: `master_clinical.csv`  
- Analysis script generates: `reports/summary.md` with HbA1c statistics & noninferiority check  
